Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

Poon leaving J&J: Johnson & Johnson has more than five months to choose the next global head of its Pharmaceuticals Group as Christine A. Poon announces she will retire in March 2009 after more than 23 years in the health care industry and eight years with the company. The firm says Poon, who also is vice chair of the board of directors, has not indicated whether she plans to continue working in the pharmaceutical industry. In an e-mail to company employees Poon said she will work with the firm "to successfully close 2008, complete plans for 2009 and provide assistance for an orderly transition." She added she has "a deep desire to take on new challenges and find opportunities to advance society and health through my continuing involvement with science, technology, innovation and business." Poon joined J&J in 2000 as group chairman for pharmaceuticals before being promoted to the executive committee and named worldwide chairman for pharmaceuticals in 2001 and worldwide chairman for medicines and nutritionals in 2003. She was elected to the board and named vice chair in 2005 and returned to the pharmaceutical post in 2007

You may also be interested in...



Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014

French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years

Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014

French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years

Sanofi-Aventis Acquisitions Could Double OTC Sales By 2014

French drug maker Sanofi-Aventis is establishing an OTC division and plans to double revenues from nonprescription drug products within five years

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102104

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel